NEOMYCIN SULPHATE UPJOHN MEDICANT FOR LIVESTOCK AND POULTRY Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neomycin sulphate upjohn medicant for livestock and poultry

pfizer animal health a div of pfizer australia pty ltd - neomycin - nutrition & metabolism - cattle | pigs | poultry broilers (meat for human consum) | poultry layers (eggs for human consump) | turkeys | beef | boar | bos - antibiotic - anti-infective | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed efficiency | fungal infections | girth galls | infections | inflammed pads | itching | keratolytic | lacerations | mastitis | mycoplasmas | odours | open wounds | otitis | pruritis | queensland itch | respiratory disease | saddle rash | salmonellosis | scabs | scaly skin | sheath rot | skin irritations | sores | swine dysentery | teat cracking | teat infections | topical infections | udder sores | weight gain | wire cuts | wounds

XANOR 1 mg TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

xanor 1 mg tablet

upjohn south africa (pty) ltd - tablet - see ingredients - each tablet contains alprazolam 1,0 mg

ASPAVOR 10 TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

aspavor 10 tablet

upjohn south africa (pty) ltd - tablet - see ingredients - each tablet contains atorvastatin 10,0 mg

ASPAVOR 20 TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

aspavor 20 tablet

upjohn south africa (pty) ltd - tablet - see ingredients - each tablet contains atorvastatin 20,0 mg

ASPAVOR 40 TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

aspavor 40 tablet

upjohn south africa (pty) ltd - tablet - see ingredients - each tablet contains atorvastatin 40,0 mg

ASPAVOR 80 TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

aspavor 80 tablet

upjohn south africa (pty) ltd - tablet - see ingredients - each tablet contains atorvastatin 80,0 mg

ORBEOS 80 TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

orbeos 80 tablet

upjohn south africa (pty) ltd - tablet - see ingredients - each tablet contains atorvastatin 80,0 mg

LYRICA CR pregabalin 330mg modified release tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

lyrica cr pregabalin 330mg modified release tablet bottle

viatris pty ltd - pregabalin, quantity: 330 mg - tablet, modified release - excipient ingredients: crospovidone; polyethylene oxide; carbomer 941; magnesium stearate; colloidal anhydrous silica; povidone; sodium lauryl sulfate; polyvinyl acetate; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - lyrica cr (pregabalin) is indicated for the treatment of neuropathic pain in adults.,efficacy of lyrica cr has not been established as an adjunctive therapy for adult patients with partial seizures with or without secondary generalisation.

LYRICA CR pregabalin 165mg modified release tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

lyrica cr pregabalin 165mg modified release tablet bottle

viatris pty ltd - pregabalin, quantity: 165 mg - tablet, modified release - excipient ingredients: crospovidone; polyethylene oxide; carbomer 941; magnesium stearate; colloidal anhydrous silica; povidone; sodium lauryl sulfate; polyvinyl acetate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - lyrica cr (pregabalin) is indicated for the treatment of neuropathic pain in adults.,efficacy of lyrica cr has not been established as an adjunctive therapy for adult patients with partial seizures with or without secondary generalisation.